Friday, March 17, 2017 3:31:37 PM
BreathTec - Infectious Dieases
CEO is Torrie
CFO is also the same CFO for Finore Mining (FIN IMEXF
Cannabix - Controlled Substance
CEO is Mlait which is CEO of that Finore Mining
CFO is Loree
Now what I highlighted is why there different Company's and they also have this group working for both Company's Working the Hand Held Breathalyzer
Other than these's is another Group of Specialists that are Best of the Best in their fields
Dr. Bruce Goldberger, PhD, Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida. Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.
Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016). Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine.
Michael T. Costanzo, Ph.D., Chief Technical Officer
Dr. Costanzo enjoys a passion for science that has directed his career path firmly into the field of analytical chemistry. Over the past five years he has investigated a variety of advanced experimental methodologies and instrumentation with the Yost Research Group at the University of Florida. During this period he utilized UV spectroscopy to help in standardizing procedures for manufacturing respiratory medications, employed novel ion mobility spectrometric techniques and devices to analyze exhaled breath, and performed multiple metabolomics studies of melanoma. Through his efforts, he acquired a vast knowledge of analytical techniques and methodologies and an immense desire for scientific progress.
Previously, Costanzo obtained his Bachelor of Science in chemistry at the State University of New York (Buffalo). During this period he conducted research under Dr. Troy Wood utilizing mass spectrometry to examine products of enzymatic protein digestion in the interest of studying metabolic markers of autism in children. Upon graduation in 2010 he moved to the University of Florida for Ph.D. studies and as a result of his efforts has recently joined with Breathtec Biomedical to propel his own bioanalytical research through the development of revolutionary clinical devices utilizing his background in ion mobility, mass spectrometry, and exhaled breath analysis.
Prof. Hossam Haick, Consultant
Dr. Haick is a full Professor in Chemical Engineering and Nanotechnology at the Technion Israel Institute of Technology and an expert in the field of nanotechnology and non-invasive disease diagnosis. Dr. Haick is the recipient of the prestigious Marie Curie Excellence Award, ERC Award, and the FP-7 and Horizon 2020 consortium Awards. He is also the recipient of more than 56 international honors and prizes for his achievements. Prof. Haick has published over 170 articles and serves on the editorial board of several peer-reviewed journals, and is a senior scientific advisory member of several national and international companies and institutes. Prof. Haick’s ground-breaking research has led to the development of the NA-NOSE nanotechnology-based breath test technology for detecting biomarkers of disease. Certain disease conditions produce chemicals called volatile organic compounds (VOCs), which easily evaporate into the air and produce a discernible scent profile. The Na-NOSE chip detects the unique “signature” of VOCs in exhaled breath. As a consultant to Breathtec, Prof. Haick will guide the company’s development of the NA-NOSE disease detection system and design the clinical trials to be undertaken by the company.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM